{
  "report_rows": [
    {
      "kpi": "Adj. EBITDA (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$1,750M vs. cons $1,638M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "EBITDA - Texas/ERCOT (Q2 2026)",
      "prediction": "MISS",
      "answer": "pred ~$240M vs. cons $303M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "EBITDA - East/PJM (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$720M vs. cons $618M",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Adj. EBITDA (FY 2026)",
      "prediction": "BETTER",
      "answer": "guide ~$7.5B mid vs. cons $7,385M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adj. EBITDA (FY 2027)",
      "prediction": "UNCHANGED",
      "answer": "guide maintained vs. cons $8,320M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Nuclear contracting tone (qualitative)",
      "prediction": "BETTER",
      "answer": "progress update or new deal signal vs. no update",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": 5.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 7.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH - estimate revisions follow the FY raise; back-half consensus moves up, pulling the stock higher over 5 days",
  "day5_confidence": "MEDIUM"
}